Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS/HIV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Large-scale testing (Phase 3)Study completedNCT03656783
What this trial is testing

Effects of Biktarvy on CFR in Stable HIV Patients

Who this might be right for
HIV
Brigham and Women's Hospital 25
Large-scale testing (Phase 3)Study completedNCT02660905
What this trial is testing

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Who this might be right for
Human Immunodeficiency VirusHepatitis C, Chronic
Ottawa Hospital Research Institute 25
Not applicableStudy completedNCT01804907
What this trial is testing

Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV

Who this might be right for
InsomniaSleep Efficiency
Duke University 36
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT05016232
What this trial is testing

Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women

Who this might be right for
Prevention
University of California, Los Angeles 123
Not applicableStudy completedNCT01886404
What this trial is testing

EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients

Who this might be right for
HIV Infection
University of Nebraska 30
Testing effectiveness (Phase 2)Study completedNCT00333684
What this trial is testing

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Who this might be right for
Human Immunodeficiency VirusFacial Lipoatrophy
Canadian Immunodeficiency Research Collaborative 36
Not applicableWithdrawnNCT03964584
What this trial is testing

Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real Life

Who this might be right for
HIV+ Patients
Fondation Ophtalmologique Adolphe de Rothschild
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Not applicableStudy completedNCT01413152
What this trial is testing

Residual Risk Assessment Of HIV Transmission

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 167
Post-approval studies (Phase 4)Study completedNCT02547844
What this trial is testing

Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

Who this might be right for
HIV-1
Hospital Universitari Vall d'Hebron Research Institute 30
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Testing effectiveness (Phase 2)Study completedNCT00035893
What this trial is testing

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Who this might be right for
HIV SeropositivityHIV Infection
AIM ImmunoTech Inc. 40
Not applicableStudy completedNCT05084716
What this trial is testing

Pre-Exposure Prophylaxis (PrEP) Provision for Ugandan Fisherfolk

Who this might be right for
HIV
RAND 885
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT00001133
What this trial is testing

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT01020552
What this trial is testing

Integrating Family Planning Into Postabortion Care

Who this might be right for
Postabortion Care
FHI 360 300
Large-scale testing (Phase 3)Active Not RecruitingNCT04255849
What this trial is testing

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaHIV-1-infectionHPV Infection
Weill Medical College of Cornell University 700
Not applicableLooking for participantsNCT07563309
What this trial is testing

Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

Who this might be right for
HIV 1 InfectionHIV 2 InfectionSyphilis Infection+1 more
bioLytical Laboratories 1,000
Next Page